Global preclinical research and clinical specialty testing provider driving excellence in oncology drug development programs.

Sectors
Healthcare
Life Sciences
First Invested
2015
Public/PIPES
Company Status
IPO/Public
NASDAQ: CSBR
Associated Team
Paul Walker